Table 3 Microbiological results
Laboratory tests | Pre-intervention n = 297 | Post-intervention n = 112 | p valuea |
|---|---|---|---|
Gram, n (%) | |||
With bacteria | 3 (1.0%) | 3 (2.7%) | 0.380 |
Without bacteria | 293 (98.7%) | 109 (97.3%) | |
No data | 1 (0.3%) | – | |
Culture, n (%) | |||
Positive | 1 (0.3%) | 2 (1.8%) | 0.126 |
S. pneumoniae | – | 1 (50%) | |
N. meningitidis | 1 (100%) | – | |
S. agalactiae | – | 1 (50%) | |
Negative | 296 (99.7%) | 110 (98.2%) | |
Blood culture, n (%) | |||
Positive | 15 (5.1%) | 6 (5.4%) | 0.289 |
S. pneumoniae | – | 1 (16.7%) | |
N. meningitidis | 1 (6.7%) | 1 (16.7%) | |
S. agalactiae | 2 (13.3%) | 3 (50%) | |
E. coli | 2 (13.3%) | 1 (16.6%) | |
S. epidermis | 3 (20.0%) | – | |
S. aureus | 4 (26.6%) | – | |
S. parasanguinis | 1 (6.7%) | – | |
E. faecalis | 1 (6.7%) | – | |
S. pyogenes | 1 (6.7%) | – | |
Negative | 274 (92.3%) | 101 (90.2%) | |
Unrealized-No data | 8 (2.7%) | 5 (4.5%) | |
Molecular testb, n (%) | |||
Positive | 10 (3.4%) | 27 (24.1%) | < 0.001 |
Enterovirus | 3 (30%) | 14 (51.9%) | |
Parechovirus | – | 3 (11.1%) | |
HSV1 | 1 (10%) | – | |
VZV | 4 (40%) | – | |
CMV | 2 (20%) | – | |
HHV-6 | – | 3 (11.1%) | |
S. pneumoniae | – | 4 (14.8%) | |
N. meningitidis | – | 1 (3.7%) | |
H. influenzae | – | 1 (3.7%) | |
S. agalactiae | – | 1 (3.7%) | |
Negative | 31 (10.4%) | 86 (76.8%) | |
Unrealized | 256 (86.2%) | – | |
Overallc, n (%) | |||
Positive | 28 (9.4%) | 30 (26.8%) | < 0.001 |
Negative | 29 (9.4%) | 82 (73.2%) | |
Unrealized | 241 (81.1%) | – | |
Altered LCR, n (%) | 76 (25.6) | 53 (47.3) | < 0.001 |
Positivity in altered LCR, n (%) | 7 (9.2%) | 17 (32.1%) | 0.001 |